Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Riethmüller

Showing results (41-50 of 253) with videos related to

Pageof 26
Sort By:
Scandinavian Journal of Immunology|January 1, 1976
Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assayJ G Saal, E P Rieber, G Riethmüller
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamilyJ M Lehmann, G Riethmüller, J P Johnson
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic seriesH Szöts, G Riethmüller, E Weiss, et al.
European Journal of Immunology|December 1, 1988
The tumor progression-associated human melanoma antigen P3.58 mediates monocyte-lymphocyte interactions in vitroJ P Johnson, J M Lehmann, G Riethmüller
Lancet (London, England)|February 20, 1993
Micrometastatic tumour cells in bone marrow in colorectal cancerK Pantel, S Braun, G Schlimok, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2001
Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigensT Raum, R Gruber, G Riethmüller, et al.
Current Opinion in Immunology|October 1, 1993
Monoclonal antibodies in cancer therapyG Riethmüller, E Schneider-Gädicke, J P Johnson
Nucleic Acids Research|February 25, 1990
Nck, a melanoma cDNA encoding a cytoplasmic protein consisting of the src homology units SH2 and SH3J M Lehmann, G Riethmüller, J P Johnson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cellsA Zippelius, R Lutterbüse, G Riethmüller, et al.
British Journal of Cancer|October 1, 1983
Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cellsH W Ziegler-Heitbrock, J Erhardt, G Riethmüller
Pageof 26

Showing results (41-50 of 253) with videos related to

Sort By:
Pageof 26
Scandinavian Journal of Immunology|January 1, 1976
Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assayJ G Saal, E P Rieber, G Riethmüller
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1989
MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamilyJ M Lehmann, G Riethmüller, J P Johnson
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1986
Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic seriesH Szöts, G Riethmüller, E Weiss, et al.
European Journal of Immunology|December 1, 1988
The tumor progression-associated human melanoma antigen P3.58 mediates monocyte-lymphocyte interactions in vitroJ P Johnson, J M Lehmann, G Riethmüller
Lancet (London, England)|February 20, 1993
Micrometastatic tumour cells in bone marrow in colorectal cancerK Pantel, S Braun, G Schlimok, et al.
Cancer Immunology, Immunotherapy : CII|June 23, 2001
Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigensT Raum, R Gruber, G Riethmüller, et al.
Current Opinion in Immunology|October 1, 1993
Monoclonal antibodies in cancer therapyG Riethmüller, E Schneider-Gädicke, J P Johnson
Nucleic Acids Research|February 25, 1990
Nck, a melanoma cDNA encoding a cytoplasmic protein consisting of the src homology units SH2 and SH3J M Lehmann, G Riethmüller, J P Johnson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cellsA Zippelius, R Lutterbüse, G Riethmüller, et al.
British Journal of Cancer|October 1, 1983
Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cellsH W Ziegler-Heitbrock, J Erhardt, G Riethmüller
Pageof 26